Showing 1 - 20 results of 21 for search 'T. L. J. Tammela', query time: 0.05s
Refine Results
-
1
-
2
Statin use and outcomes of oncological treatment for castration-resistant prostate cancer by A. I. Peltomaa, K. Talala, K. Taari, T. L. J. Tammela, A. Auvinen, T. J. Murtola
Published 2023-11-01
Article -
3
-
4
Antihypertensive drug use and prostate cancer-specific mortality in Finnish men. by Aino Siltari, Teemu J Murtola, Kirsi Talala, Kimmo Taari, Teuvo L J Tammela, Anssi Auvinen
Published 2020-01-01
Article -
5
Outcomes of prostate cancer screening among men using antidiabetic medication by A. Vettenranta, T. J. Murtola, K. Talala, K. Taari, U.-H. Stenman, T. L. J. Tammela, A. Auvinen
Published 2021-04-01
Article -
6
-
7
Expression and ERG regulation of PIM kinases in prostate cancer by Sini K. Eerola, Annika Kohvakka, Teuvo L. J. Tammela, Päivi J. Koskinen, Leena Latonen, Tapio Visakorpi
Published 2021-05-01
Article -
8
-
9
-
10
-
11
Long‐term health‐related quality of life among men with prostate cancer in the Finnish randomized study of screening for prostate cancer by Kirsi Talala, Sirpa Heinävaara, Kimmo Taari, Teuvo L. J. Tammela, Paula Kujala, Ulf‐Håkan Stenman, Nea Malila, Anssi Auvinen
Published 2020-08-01
Article -
12
-
13
-
14
Atorvastatin induces adrenal androgen downshift in men with prostate cancer: A post Hoc analysis of a pilot adaptive Randomised clinical trial by Paavo V.H. Raittinen, Heimo Syvälä, Teuvo L.J. Tammela, Merja R. Häkkinen, Pauliina Ilmonen, Seppo Auriola, Teemu J. Murtola
Published 2021-06-01
Article -
15
Prognostic Index for Predicting Prostate Cancer Survival in a Randomized Screening Trial: Development and Validation by Subas Neupane, Jaakko Nevalainen, Jani Raitanen, Kirsi Talala, Paula Kujala, Kimmo Taari, Teuvo L. J. Tammela, Ewout W. Steyerberg, Anssi Auvinen
Published 2021-01-01
Article -
16
Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer. by Liisa Sjöblom, Outi Saramäki, Matti Annala, Katri Leinonen, Janika Nättinen, Teemu Tolonen, Tiina Wahlfors, Matti Nykter, G Steven Bova, Johanna Schleutker, Teuvo L J Tammela, Hans Lilja, Tapio Visakorpi
Published 2016-01-01
Article -
17
Efficacy and safety of darolutamide (DARO) in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) and a prostate-specific antigen doubling time (PSADT) >6 mo... by M.W.H. Bögemann, N.D. Shore, T.L.J. Tammela, A. Ulys, E. Vjaters, S. Polyakov, M. Jievaltas, M. Luz, B. Alekseev, I. Kuss, M-A. Le Berre, A. Snapir, T. Sarapohja, K. Fizazi
Published 2020-07-01
Article -
18
Expected impact of MRI related interreader variability on ProScreen prostate cancer screening trial by R. Hietikko, T.P. Kilpeläinen, A. Kenttämies, J. Ronkainen, K. Ijäs, K. Lind, S. Marjasuo, J. Oksala, O. Oksanen, T. Saarinen, R. Savolainen, K. Taari, T.L.J. Tammela, T. Mirtti, K. Natunen, A. Auvinen, A. Rannikko
Published 2020-07-01
Article -
19
Expected impact of MRI-related interreader variability on ProScreen prostate cancer screening trial: a pre-trial validation study by Ronja Hietikko, Tuomas P. Kilpeläinen, Anu Kenttämies, Johanna Ronkainen, Kirsty Ijäs, Kati Lind, Suvi Marjasuo, Juha Oksala, Outi Oksanen, Tuomas Saarinen, Ritja Savolainen, Kimmo Taari, Teuvo L. J. Tammela, Tuomas Mirtti, Kari Natunen, Anssi Auvinen, Antti Rannikko
Published 2020-10-01
Article -
20
Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer by Alfonso Urbanucci, Stefan J. Barfeld, Ville Kytölä, Harri M. Itkonen, Ilsa M. Coleman, Daniel Vodák, Liisa Sjöblom, Xia Sheng, Teemu Tolonen, Sarah Minner, Christoph Burdelski, Kati K. Kivinummi, Annika Kohvakka, Steven Kregel, Mandeep Takhar, Mohammed Alshalalfa, Elai Davicioni, Nicholas Erho, Paul Lloyd, R. Jeffrey Karnes, Ashley E. Ross, Edward M. Schaeffer, Donald J. Vander Griend, Stefan Knapp, Eva Corey, Felix Y. Feng, Peter S. Nelson, Fahri Saatcioglu, Karen E. Knudsen, Teuvo L.J. Tammela, Guido Sauter, Thorsten Schlomm, Matti Nykter, Tapio Visakorpi, Ian G. Mills
Published 2017-06-01
Article